Today, prominent investor rights law firm Bernstein Litowitz Berger & Grossmann LLP ("BLB&G") filed a class action in the U.S. District Court for the Southern District of New York alleging violations ...
Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a global insulin delivery and diabetes technology company, today announced that the U.S. Food and Drug Administration (FDA) has cleared the Android version ...
Continuous glucose monitoring can identify unrecognized hyperglycemia and hypoglycemia in dialysis patients, challenging ...
However, the company's financial results have been pretty strong. And if DexCom can keep that up in its next quarterly update ...
Tennessee athletics director Danny White is embarking on a national search for a new baseball manager following the San Francisco Giants' historic hiring of Tony Vitello on Wednesday, but is not ...
Stifel projected that the 15-day sensor could enhance DexCom’s gross margin in 2026, potentially contributing to year-over-year EBITDA margin expansion. The firm acknowledged certain risks, including ...
Investing.com - Stifel resumed coverage of DexCom (NASDAQ:DXCM) with a Buy rating and set a price target of $85.00, according to a research note published Monday. The company, currently trading at $68 ...
Ange Postecoglou sacked after just 39 days in charge following 3-0 home defeat to Chelsea; Dyche is understood to be frontrunner to replace him; Roberto Mancini and Marco Silva also in the frame Image ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback